Overview

Optimal Dosage of Remifentanil for Vertebroplasty

Status:
Not yet recruiting

Trial end date:
2025-04-01

Target enrollment:

Participant gender:

Summary

Percutaneous vertebroplasty has become a mainstay in the management of osteoporotic and malignant vertebral fractures. Procedural analgesia and sedation (PAS) with propofol and remifentanil may provides optimal hypnotic and analgesic effects.

Phase:

Phase 4

Details

Lead Sponsor:

Tri-Service General Hospital

Treatments:

Remifentanil